French biotech company Ipsen to buy Kartos Therapeutics for $450 million

Markets Investing.com By Reuters 29 Jun 2026 08:24 1 min read

French biotech company Ipsen to buy Kartos Therapeutics for $450 million

French biotech company Ipsen to buy Kartos Therapeutics for $450 million

French biotech company Ipsen to buy Kartos Therapeutics for $450 million

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.